We are live on ! Find out more
CSCI

COSCIENS Biopharma Inc. Common Stock
CSCI

Delisted

CSCI was delisted on the 3rd of September, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of CSCI yet.

CSCI Hedge Fund Activity: Q4 2025 in Review

0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in COSCIENS Biopharma Inc. Common Stock (CSCI) for Q4 2025, worth a combined $0 — down 100% from $10.3K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CSCI and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TD Waterhouse Canada, exiting entirely with an estimated $10.2K sold.

  • 0 institutional investors held COSCIENS Biopharma Inc. Common Stock (CSCI) as of Q4 2025, down from 2 in Q3 2025.
  • Funds reported $0 of COSCIENS Biopharma Inc. Common Stock stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new COSCIENS Biopharma Inc. Common Stock positions in Q4 2025 and 2 closed out, a net change of -2 holders.
  • The largest COSCIENS Biopharma Inc. Common Stock seller in Q4 2025 was TD Waterhouse Canada, an estimated $10.2K sold.

Based on aggregated 13F filings for Q4 2025.